India / Dr Brij Mohan – President, Diabetes & Obesity Centre, India
President of India’s Diabetes & Obesity Centre, Dr Brij Mohan has an extensive background in the field of diabetes, having served on the board of Diabetes India and as president…
Address: W-199-E, MIDC Khairne, Thane Belapur Road,Navi Mumbai – 400705.,India
Tel: +91-22-4151 5151
Web: http://www.nilsan-nishotech.com/
The Company Started in 1989 as a PROCESS ENGINEERING COMPANY & is today one of the most accomplished and diversified business houses in India having head office in Mumbai , branch office at Hyderabad. At NILSAN Nishotech we have two SBU’S SEPTECH & EPMG. The Group’s success has been driven by the company’s commitment to delivering innovation and excellence. Through the consistent application of this commitment and a century of ethical business conduct, Nilsan Nishotech has earned an unparalleled reputation for trust a,nd reliability.
In 23 years, NILSAN Nishotech is the first company in India to develop the technology to support Pharma, Bio-Pharma , Sugar , Food & Healthcare customers; this spirit of innovation has continued throughout the organization’s history. Today NILSAN Nishotech is delivering exciting engineering innovative solutions across a spectrum of businesses. The company’s pursuit of excellence is equally well established and enduring. NILSAN Nishotech’s management understands that the company’s greatest asset is the trust and faith that customers have reposed in it, and recognizes that the company must continue to earn this trust. This translates to the organization delivering outstanding quality and value in everything it does. We have Overseas association with French Company Novasep (Chromatography Columns) , Austar –China (RO+EDI Skid) , Ziemann –India (Tanks) , DrM – Switzerland (Candle Filtration System) for which we stand one point contact in India.
Sterile Process Piping, Separation Technologies, Pharma Water Technologies
President of India’s Diabetes & Obesity Centre, Dr Brij Mohan has an extensive background in the field of diabetes, having served on the board of Diabetes India and as president…
A pioneer in caster oil-based chemicals and pharmaceutical-grade products, Jayant Agro-Organics accounts for some 35 to 40 percent of the global castor oil market. Chairman Abhay V. Udeshi explains the audit…
India’s National Chemical Laboratory (NCL), one of the most well-established labs in the wider Council of Scientific and Industrial Research (CSIR) network, has made some major contributions to improving the…
Sanjay Bhutani of Bausch & Lomb outlines why the medical devices sector in India is poised for substantial growth, bolstered by increased government support and a higher healthcare budget. He…
Regular contributor Brendan Shaw gives his informed take on how best international stakeholders can engage with India’s attempts to transform into a global pharma innovation powerhouse, Our greatest ability…
Dr Santosh Indraksha serves as Deputy Drugs Controller (India) for the Central Drugs Standard Control Organisation (CDSCO) under the Indian Ministry of Health and Family Welfare. As a representative of…
Clinical trials will be a pivotal part of India’s attempts to scale the global pharmaceutical value chain. Following a series of well-publicised scandals in the early 2010s, the country tightened…
Dr Viranchi Shah of Saga Lifesciences and the Indian Drug Manufacturers Association (IDMA) outlines the Indian pharmaceutical industry’s potential for growth and its role in global health initiatives. He highlights…
Drawing on a unique background in both medicine and law, Dr Milind Antani today leads the pharma and healthcare practice at Nishith Desai Associates, covering everything from regulatory work to…
J&J India’s Jayashri Kulkarni lays out her approach to comprehensive leadership, drawing on her diverse career history across various sectors; her mandate to leverage innovative assets to transform disease management…
Shailesh Siroya explains the rationale behind Bal Pharma’s strategic focus on niche products within the API segment, avoiding the broader, more competitive commodity markets and enabling it to establish a…
Multinational life science firms have been present in India for decades. However, they have often eschewed bringing their latest products to a country that has long prioritised affordability above innovation.…
See our Cookie Privacy Policy Here